RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/21575866http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/21575866http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/21575866http://www.w3.org/2000/01/rdf-schema#comment"Anaplastic lymphoma kinase (ALK) is a tyrosine kinase that is constitutively activated in certain cancers, following gene alterations such as chromosomal translocation, amplification, or point mutation. Here, we identified CH5424802, a potent, selective, and orally available ALK inhibitor with a unique chemical scaffold, showing preferential antitumor activity against cancers with gene alterations of ALK, such as nonsmall cell lung cancer (NSCLC) cells expressing EML4-ALK fusion and anaplastic large-cell lymphoma (ALCL) cells expressing NPM-ALK fusion in vitro and in vivo. CH5424802 inhibited ALK L1196M, which corresponds to the gatekeeper mutation conferring common resistance to kinase inhibitors, and blocked EML4-ALK L1196M-driven cell growth. Our results support the potential for clinical evaluation of CH5424802 for the treatment of patients with ALK-driven tumors."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.org/dc/terms/identifier"doi:10.1016/j.ccr.2011.04.004"xsd:string
http://purl.uniprot.org/citations/21575866http://purl.org/dc/terms/identifier"doi:10.1016/j.ccr.2011.04.004"xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Kodama T."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Kodama T."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Kobayashi T."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Kobayashi T."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Ishii N."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Ishii N."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Sakamoto H."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Sakamoto H."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Aoki Y."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Aoki Y."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Fukami T.A."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Fukami T.A."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Hiroshima S."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Hiroshima S."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Oikawa N."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Oikawa N."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Tsukaguchi T."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Tsukaguchi T."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Tsukuda T."xsd:string
http://purl.uniprot.org/citations/21575866http://purl.uniprot.org/core/author"Tsukuda T."xsd:string